A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases
about
A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A Proof of Concept, Phase II R ...... ents with Acute Liver Diseases
@ast
A Proof of Concept, Phase II R ...... ents with Acute Liver Diseases
@en
A Proof of Concept, Phase II R ...... ents with Acute Liver Diseases
@nl
type
label
A Proof of Concept, Phase II R ...... ents with Acute Liver Diseases
@ast
A Proof of Concept, Phase II R ...... ents with Acute Liver Diseases
@en
A Proof of Concept, Phase II R ...... ents with Acute Liver Diseases
@nl
prefLabel
A Proof of Concept, Phase II R ...... ents with Acute Liver Diseases
@ast
A Proof of Concept, Phase II R ...... ents with Acute Liver Diseases
@en
A Proof of Concept, Phase II R ...... ents with Acute Liver Diseases
@nl
P2093
P2860
P50
P1433
P1476
A Proof of Concept, Phase II R ...... ents with Acute Liver Diseases
@en
P2093
Christian Bréchot
Christian Trautwein
Christophe Duvoux
Didier Samuel
Dominique Larrey
François Durand
Gilles Amouyal
Jacques Bernuau
Laure Jamot
Marika Rudler
P2860
P304
P356
10.1371/JOURNAL.PONE.0150733
P407
P577
2016-01-01T00:00:00Z